Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.

Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.

Allergy Asthma Proc. 2012 Nov-Dec;33(6):450-8. doi: 10.2500/aap.2012.33.3626. Epub 2012 Nov 2.

PMID:
23127291
2.
3.

Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.

LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M.

Allergy Asthma Proc. 2010 Mar-Apr;31(2):132-40. doi: 10.2500/aap.2010.31.3326. Epub 2010 Mar 18.

PMID:
20302683
4.

Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.

Meltzer E, Ratner P, Bachert C, Carr W, Berger W, Canonica GW, Hadley J, Lieberman P, Hampel FC, Mullol J, Munzel U, Price D, Scadding G, Virchow JC, Wahn U, Murray R, Bousquet J.

Int Arch Allergy Immunol. 2013;161(4):369-77. doi: 10.1159/000351404. Epub 2013 May 4.

5.

Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.

Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.

Ann Allergy Asthma Immunol. 2008 Jan;100(1):74-81. doi: 10.1016/S1081-1206(10)60408-5.

PMID:
18254486
6.

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.

Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D, Munzel U, Bousquet J.

J Allergy Clin Immunol. 2012 May;129(5):1282-1289.e10. doi: 10.1016/j.jaci.2012.01.077. Epub 2012 Mar 13.

PMID:
22418065
7.

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.

Derendorf H, Munzel U, Petzold U, Maus J, Mascher H, Hermann R, Bousquet J.

Br J Clin Pharmacol. 2012 Jul;74(1):125-33. doi: 10.1111/j.1365-2125.2012.04222.x.

8.
9.

Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.

Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H; Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.

Clin Ther. 2005 May;27(5):543-53.

PMID:
15978303
10.

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.

Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.

Ann Allergy Asthma Immunol. 2010 Aug;105(2):168-73. doi: 10.1016/j.anai.2010.06.008.

PMID:
20674829
11.

The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.

DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA.

Allergy Asthma Proc. 2003 Sep-Oct;24(5):331-7.

PMID:
14619333
12.

Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.

Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Bousquet J.

Pediatr Allergy Immunol. 2016 Mar;27(2):126-33. doi: 10.1111/pai.12540.

PMID:
26928753
13.

A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.

Price D, Shah S, Bhatia S, Bachert C, Berger W, Bousquet J, Carr W, Hellings P, Munzel U, Scadding G, Lieberman P.

J Investig Allergol Clin Immunol. 2013;23(7):495-503.

14.

Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis.

Ratner P, Van Bavel J, Mohar D, Jacobs RL, Hampel F, Howland W, Karwal R.

Ann Allergy Asthma Immunol. 2015 Feb;114(2):141-7. doi: 10.1016/j.anai.2014.11.012.

PMID:
25624132
15.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
16.

Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.

Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B.

Allergy Asthma Proc. 2009 May-Jun;30(3):255-62. doi: 10.2500/aap.2009.30.3232.

PMID:
19549426
18.

New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.

Wolthers OD.

Recent Pat Inflamm Allergy Drug Discov. 2013 Sep;7(3):223-8. Review.

PMID:
23862774
19.

Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis.

Grossman J, Banov C, Bronsky EA, Nathan RA, Pearlman D, Winder JA, Ratner PH, Mendelson L, Findlay SR, Kral KM, et al.

Pediatrics. 1993 Oct;92(4):594-9.

PMID:
8414833
20.

Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.

Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA.

Clin Exp Allergy. 2004 Jun;34(6):952-7.

PMID:
15196285

Supplemental Content

Support Center